the Prevention of Bone Marrow Suppression Caused by Chemotherapy in Advanced NSCLC With Trilaciclib
Conditions: Non-small Cell Lung Cancer Interventions: Drug: Trilaciclib Sponsors: Henan Cancer Hospital; Jiangsu Simcere Pharmaceutical Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Chemotherapy | Hospitals | Lung Cancer | Non-Small Cell Lung Cancer | Research